Detalhe da pesquisa
1.
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor.
Cancer Discov
; 5(7): 713-22, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934077